Signals, Powered By EquityPandit
Granules India, has received Establishment Inspection Report(EIR), for the OmniChem facility at Vizag, Andhra Pradesh, from the US health regulator.
In a BSE filing it stated,OmniChem facility is operated by 50:50 joint venture of Granules India and Ajinimoto OmniChem N V.
As per Granules India,”This facility was inspected by the USFDA in December 2016 and there were seven observations during the inspection. The facility manufactures Active Pharmaceutical Ingredients(API) intermediates.”
